5 November 2019 By Catherine Lamontagne Comments are Off Network

Number of early-stage clinical studies at the CHU de Québec Research Centreabout to double

The CHU de Québec-Université Laval (CRCHU) Research Centre has worked extra hard this year to stimulate launches of early-stage clinical research projects in the Quebec City region. The Research Centre is about to double the number of clinical trials conducted in its institutions.

The largest French-language research centre in North America, the CRCHU intends to launch more than 25 early-stage clinical research projects by the end of the year, compared to 13 in 2018.The CRCHU is a leader in cancer research; as a result, many of these projects are in areas such as radiation oncology, pediatric oncology, urology, breast cancer and dermatology. CRCHU researchers also excel in other specialties, including endocrinology, infectious diseasesand neurology.

This increase in the number of early-stage clinical trials was driven mainly by new grant money awarded to the CHU de Québec-UniversitéLaval for new project launches. As a result, researchers initiating early-stage clinical research projects were able to benefit from financial assistance. This program exists thanks to financial support provided by CATALIS Québec, an initiative of the Ministère de l’Économie et de l’Innovation du Québec, whose goal is to promote Quebec’s expertise in the conduct of early-stage clinical trials.

Since the launch of the funding program, a total of $25,000 has been awarded to 11 CHU de Québec-Université Laval clinician-researchers.

Several patients from the Quebec City region and from throughout Eastern Quebec have been able to benefit from the increase in the number of clinical trials at the CRCHU. These trials have given them access to innovative treatment approaches that can sometimes prolong life or improve its quality.

The researchers who have launched early-stage clinical research projects through the financial support of CATALIS Québec are: